Evidence map›Paper›PMID 41783068›Full record

ArticleFrontiers in medicine2026

Awareness of HPV and HPV vaccine among women with high-risk HPV types in the Mediterranean region.

Serhan Can İşcan, Ufuk Atlıhan, Gökçe İşcan, Selçuk Erkılınç

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Serhan Can İşcanDepartmant of Gynecology, Kütahya Health Sciences University, Kütahya, Türkiye.
Ufuk AtlıhanDepartmant of Gynecology, Buca Seyfi Demirsoy Training and Research Hospital, İzmir Democracy University, İzmir, Türkiye.
Gökçe İşcanDepartmant of Gynecology, Kütahya Health Sciences University, Kütahya, Türkiye.
Selçuk ErkılınçFaculty of Medicine, İzmir Democracy University, Karabağlar, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To evaluate awareness of HPV and the HPV vaccine among women with high-risk HPV types in the Mediterranean region. Methods: This observational cross-sectional study included 1,418 women who underwent colposcopy due to high-risk HPV positivity. Seven hundred seventy-six participants who fully completed the survey and provided all requisite data for the study were assessed. A survey containing 9 questions about HPV, HPV vaccine, and the source of information of HPV, relationship between HPV and cervical cancer was applied to patients who were given a colposcopy appointment due to high-risk HPV positivity. Results: Seventy percent of women underwent an HPV test during a visit to the doctor, while the proportion of those tested for screening purposes was identified as 22.2%. About 79.5% of participants reported lacking any awareness of HPV before undergoing the test. The source of their initial information of HPV, 49.2% of participants indicated health experts, while 31.4% cited social media. The percentage of participants informed about the HPV vaccine is 20.7%. Only 8.9% of participants reported receiving vaccinations. Conclusion: The fact that even women with a positive HPV test who are referred to the gynecological oncology clinic and who are in risk groups for cervical cancer have limited knowledge about HPV and the HPV vaccine shows how important it is to raise awareness in society about this issue. The use of social media, particularly the creation of content by healthcare professionals, appears to be a crucial measure for raising awareness of HPV and the HPV vaccine.

Indexed as

cervical cancerhigh-risk HPVHPVHPV vaccinehuman papillomavirus

Identifiers

PMID41783068
PMCPMC12953068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.